Clinical Trials in Tennessee

Showing 15741-15760 of 17,345 trials

Cetuximab & Celecoxib for Metastatic Colorectal Cancer or Colorectal Cancer That Cannot Be Removed by Surgery

NCT00466505

RATIONALE: Monoclonal antibodies, such as cetuximab, can block tumor growth in different ways. Some block the ability of tumor cells to grow and spread. Others find tumor cells and help kill them or carry tumor-killing substances to them. Cetuximab may also stop the growth of colorectal cancer by blocking blood flow to the tumor. Celecoxib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Giving cetuximab together with celecoxib may kill more tumor cells. PURPOSE: This phase II trial is studying how well giving cetuximab together with celecoxib works in treating patients with metastatic colorectal cancer or colorectal cancer that cannot be removed by surgery.

Colorectal Cancer

Vanderbilt-Ingram Cancer Center17 participantsStarted May 2005

Nashville, Tennessee, United States

COMPLETEDPhase 329 miles

NUCYNTA (Tapentadol Immediate Release) Versus Oxycodone Immediate Release in the Treatment of Acute Low Back Pain

NCT00986180

Evaluate how NUCYNTA (tapentadol) immediate release (IR) compares with oxycodone IR in the treatment of acute low back pain.

PainBack PainLow Back Pain+1 more

Ortho-McNeil Janssen Scientific Affairs, LLC667 participantsStarted Sep 2009

Mobile, Alabama, United States • Phoenix, Arizona, United States • Jonesboro, Arkansas, United States +71 more locations

Cetuximab & Celecoxib for Metastatic Colorectal Cancer or Colorectal Cancer That Cannot Be Removed by Surgery

NUCYNTA (Tapentadol Immediate Release) Versus Oxycodone Immediate Release in the Treatment of Acute Low Back Pain

Find Trials by Condition in Tennessee

A 12-week Study of 4 Doses of VX-509 in Subjects With Active Rheumatoid Arthritis

A Study of the Effects of RoActemra/Actemra on Vaccination in Patients With Rheumatoid Arthritis on Background Methotrexate (VISARA)

Screening for Early Evidence of Diabetes

Study of Citicoline for the Treatment of Traumatic Brain Injury (COBRIT)

Study of Acid Reflux in Asthma

Evaluation of Low Source of Signal in SCOUT DS

The Efficacy and Safety of Degarelix One Month Dosing Regimens in Prostate Cancer

Immunogenicity of a Split, Cell-Based, Inactivated, Trivalent Influenza Vaccine in Healthy Adult Subjects

Safety and Efficacy of Once-daily Oral Administrations of TZP-102 for Gastroparesis in Patients With Diabetes Mellitus

Efficacy and Safety of IPI-504 With Trastuzumab Pretreated, Locally Advanced or Metastatic HER2 Positive Breast Cancer

Phase 1 Study of MDX-1401 in Patients With CD30-positive Refractory/Relapsed Hodgkin's Lymphoma

Treatment of Patients With Newly Diagnosed Acute Myeloid Leukemia or Myelodysplasia

Xpress Digital Mammography System Images for Computer Aided Detection Development

Effectiveness and Safety of 3 Dosing Regimens of CP-690,550 to Placebo in Subjects With Moderate to Severe Chronic Plaque Psoriasis

Observational Evaluation of the Peristomal Skin Condition in Ostomates

Phase I/II Safety Study of IPI-504 in Relapsed/Refractory Stage IIIb, or Stage IV Non-small Cell Lung Cancer (NSCLC)

A Safety and Efficacy Study of Two Japanese Encephalitis Vaccines ChimeriVax™-JE and JE-VAX

Validation of PROMIS Banks With COPD Exacerbations